# Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A

**Authors:** Shahram Attarian, Peter Young, Thomas H. Brannagan, David Adams, Philip Van Damme, Florian P. Thomas, Carlos Casanovas, Jafar Kafaie, Céline Tard, Maggie C. Walter, Yann Péréon, David Walk, Amro Stino, Marianne de Visser, Camiel Verhamme, Anthony Amato, Gregory Carter, Laurent Magy, Jeffrey M. Statland, Kevin Felice

PMC · DOI: 10.1186/s13023-024-03110-3 · Orphanet Journal of Rare Diseases · 2024-04-01

## Full-text entities

- **Diseases:** Charcot-Marie-Tooth type 1A. (MESH:D002607)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10985943/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC10985943/full.md

---
Source: https://tomesphere.com/paper/PMC10985943